Eric A. Widra, M.D.

Board Certified Board Certified

  • Obstetrics and Gynecology
  • Reproductive Endocrinology and Infertility

Physician Transition FAQs

Beginning in January 2024, Dr. Eric Widra will transition to a new role for SGF. Having served as Medical Director for 10 years, he will hand over those responsibilities to Dr. Lauren Roth and will become the Executive Senior Medical Officer for SGF.

No, Dr. Widra will continue to see his existing patient base in Washington, DC and through telemedicine.  However, if any patients would prefer to see a provider with more in-office availability, we are happy to arrange a transition consultation.

Dr. Widra will continue to see his existing patient base in Washington, DC and through telemedicine. If you haven’t yet had an appointment with Dr. Widra, we will schedule you with another member of SGF’s physician team in the DMV.

Dr. Widra is now the Executive Senior Medical Officer for SGF, shifting his focus more to expanding access to care for SGF’s network and patient base. Dr. Widra will also continue to serve US Fertility as VP of Development.  

Patient Testimonial
Dr. Widra was able to keep me focused on the end goal after each failed attempt, and in the end kept us on the right path to achieve a successful pregnancy.

Dr. Widra was very friendly, comforting and informative.

The best part of my experience was the clear and objective discussion with Dr. Widra and the explanation behind the options laid out.

Dr. Widra was excellent throughout our entire infertility journey. He was very clear in his diagnosis, very positive and patient, and answered all our questions.

I’ve been a patient of Dr. Widra for about two years. When we learned we were pregnant, he was there at the end to send us off and it added to the joyous moment.


Eric A. Widra, M.D., is the Executive Senior Medical Officer for Shady Grove Fertility and the associate director of the Combined Federal Fellowship in Reproductive Endocrinology and Infertility—a post-graduate training program for future leaders in this subspecialty, operated through the National Institutes of Health, Walter Reed National Military Medical Center, and Shady Grove Fertility.

Dr. Widra received his medical degree from Robert Wood Johnson Medical School and his residency training in obstetrics and gynecology at Thomas Jefferson University Hospital in Philadelphia. He completed a reproductive endocrinology and infertility fellowship at The George Washington University. Dr. Widra is currently professor and director of the Division of Reproductive Endocrinology and Infertility, Department of Clinical Obstetrics and Gynecology at Georgetown University Medical Center.

At a national level, Dr. Widra has served as chairman of the Society for Assisted Reproductive Technologies (SART) Practice Committee, a member of the SART Executive Committee, and a member of the American Society for Reproductive Medicine Practice Committee.

In addition to his clinical practice at Shady Grove Fertility, Dr. Widra supervises the extensive research activities and academic ventures of the practice. He has produced numerous publications and presentations in the field of infertility and reproductive technologies. He is board certified in obstetrics and gynecology and reproductive endocrinology and a fellow of the American Academy of Wilderness Medicine.

Read More

I find inspiration in many places—from my patients, from music and literature, and from athletics. Overcoming adversity, whether medical, intellectual, or physical, inspires me the most.


  • Residency: Obstetrics and Gynecology, Thomas Jefferson University Hospital
  • Fellowship: Reproductive Endocrinology and Infertility, The George Washington University
  • Castle Connolly’s Top Doctors, 2024
  • Northern Virginia Magazine Top Doctors (2020-2023)
  • Washingtonian’s Top Doctors for Infertility (1994-2022)
  • Physician Board at American Health Council
  • 2016 Inaugural Physicians Council Member, RESOLVE The Infertility Association
  • Washington Consumers CHECKBOOK’s Top Doctors (2015)
  • American Academy of Wilderness Medicine
  • American Society for Reproductive Medicine
  • Society for Assisted Reproductive Technologies
  • Luke B, Brown MB, Wantman E, et al. Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs. 2 embryos in 1 cycle. Am J Obstet Gynecol. 2015;212:676 e1-7.
  • Hill MJ, Royster GD, Healy MW, et al. Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation? Fertil Steril. 2015;103:1477-84.
  • Devine K, Connell MT, Richter KS, et al. Single vitrified blastocyst transfer maximizes liveborn children per embryo while minimizing preterm birth. Fertil Steril. 2015;103:1454-60.
  • Luke B, Brown MB, Wantman E, et al. A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology. Fertil Steril. 2014;102:744-52.
  • Wolff EF, Vahidi N, Alford C, Richter K, Widra E. Influences on endometrial development during intrauterine insemination: clinical experience of 2,929 patients with unexplained infertility. Fertil Steril. 2013;100:194-9 e1.
  • Hill MJ, Richter KS, Heitmann RJ, et al. Number of supernumerary vitrified blastocysts is positively correlated with implantation and live birth in single-blastocyst embryo transfers. Fertil Steril. 2013;99:1631-6.
  • Heitmann RJ, Hill MJ, Richter KS, DeCherney AH, Widra EA. The simplified SART embryo scoring system is highly correlated to implantation and live birth in single blastocyst transfers. J Assist Reprod Genet. 2013;30:563-7.
  • Manipalviratn S, Tong ZB, Stegmann B, Widra E, Carter J, DeCherney A. Effect of vitrification and thawing on human oocyte ATP concentration. Fertil Steril. 2011;95:1839-41.
  • Mesen TB, Yu B, Richter KS, Widra E, DeCherney AH, Segars JH. The prevalence of genuine empty follicle syndrome. Fertil Steril. 2011;96:1375-7.
  • Michalakis KG, Mesen TB, Brayboy LM, et al. Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes. Fertil Steril. 2011;95:2634-7.